Critical Deadline Approaches for Neogen Corporation Investors with Significant Losses

Neogen Corporation Shareholder Alert



As of September 5, 2025, investors in Neogen Corporation (NASDAQ: NEOG) are being alerted to a significant deadline impacting their ability to participate in a securities class action lawsuit. ClaimsFiler, a service dedicated to assisting investors with legal claims, reminds stakeholders that they must file lead plaintiff applications by September 16, 2025. This action concerns individuals who purchased shares of Neogen between January 5, 2023, and June 3, 2025, during what is referred to as the “Class Period.”

The lawsuit has been initiated in the United States District Court for the Western District of Michigan. The primary allegations against Neogen Corporation and some of its executives revolve around their failure to disclose crucial material information during the Class Period, which is a violation of federal securities laws. This lack of transparency has led to unfortunate financial consequences for many investors.

On April 9, 2025, Neogen Corporation revealed a concerning 3.4% decline in quarterly revenues, amounting to $221 million. The reason cited for this downturn included persistent integration issues within the company. Alongside this revelation, Neogen announced a revision of its fiscal year 2025 guidance, projecting capital expenditures of $100 million due to lowered adjusted EBITDA figures, alongside announcing the departure of its CEO. The fallout from this news saw Neogen’s stock price plummet by 28%, closing at $5.02 per share, with 47 million shares exchanged on that trading day.

Further aggravating the situation, a subsequent announcement on June 4, 2025, suggested a significant drop in projected EBITDA margins, which were now expected to be around the high-teens—a stark decline from the previous quarter’s profit margin of 22%. As a result, shares of Neogen fell another 17%, settling at $4.96 per share.

Understanding Your Rights


Investors who suffered losses exceeding $100,000 during this period are strongly encouraged to act. ClaimsFiler provides a comprehensive platform to assist shareholders in understanding their rights and the process to file claims. Interested investors can visit ClaimsFiler's website or contact their toll-free support at (844) 367-9658. Legal representatives from Kahn Swick & Foti, LLC are available to offer guidance on available legal options.

Since its inception, ClaimsFiler has sought to ensure that retail investors are equipped with essential information, helping them to reclaim their rightful share of class action settlements. The service allows users to register for free, access various securities class action cases, and receive prompt notifications if any cases may relate to their portfolio transactions.

The Importance of the Class Action


The importance of this class action cannot be understated. It serves as a critical mechanism for shareholders to band together in their fight against injustices they have faced due to a company’s mismanagement and lack of disclosure. Not only does it provide a platform for collective action, but it also aims to hold corporate executives accountable for their actions—or inactions. Additionally, it sends a powerful message to the market that transparency and ethical standards are paramount in maintaining investor trust.

Conclusion


As September 16, 2025, draws nearer, affected investors must act promptly to safeguard their interests in the Neogen Corporation case. Failing to file by this date may jeopardize their ability to recover losses. By remaining proactive and informed, shareholders can enlist the help of dedicated resources like ClaimsFiler to navigate this complex process. For more insights and to learn about your options, don’t hesitate to visit ClaimsFiler.com today.

Topics Financial Services & Investing)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.